Paul-Henri Lambert, MD, is now associated with the Centre of Vaccinology in the Department of Pathology and Immunology at University of Geneva. He is particularly interested in vaccination strategies and evaluation of adverse effects. He is directing the International Advanced Course of Vaccinology (ADVAC) organised under the auspices of the Fondation Mrieux and University of Geneva.
He is a member of the Governing Board of the Tuberculosis Vaccine Initiative (TBVI) and chairman of the Human Vaccine Committee of the International Association for Biologicals (IABS). Paul Henri Lambert is a native of Belgium where he was boarded in Internal Medicine (University of Liege). He joined Frank Dixon at Scripps Institute, La Jolla, California, for his training then moved to University of Geneva Medical School where he became professor in the Departments of Medicine and of Pathology.
His research activities lead him to decipher immunological mechanisms involved in autoimmune and immune complex-mediated diseases, in the pathogenesis of malaria and in new strategies to optimise vaccine immunogenicity. In 1987, he was appointed as chief Microbiology and Immunology at the World Health Organization and in 1994, Chief, Vaccine Research and Development, WHO Global Programme for Vaccines and Immunisation.
He was then deeply involved in co-ordination of research aiming at the development of vaccines against diseases of major importance in developing countries. Paul-Henri Lambert is author or co-author of 436 publications, member of several international scientific boards, foreign member of the Royal Academy of Medicine in Belgium and Fellow of the American Association for the Advancement of Science.
|Declarations of Conflict of Interest|